SBP solbec pharmaceuticals limited

melanoma treatment, page-2

  1. skint
    5,996 Posts.
    lightbulb Created with Sketch. 162
    clock Created with Sketch.
    07/04/05
    15:50
    Post #: 862268
    That CancerVax(CNVX) failed phase 3 trial on melanoma caused the company to lose $US88 million market cap yesterday . Nice to be in a co like Solbec where the only question is not if it kills cancer , but which cancer does it kill best , for target selection in the upcomming phase 2 trials . Even with the failed trial CNVX market cap is 5 times Solbecs .
    Cheers
    SBP Price at posting: 0.0¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS LISTEN NOW: HotCopperWire, our market watch podcast!
right-arrow Created with Sketch.
NEWS Exclusive Pre-IPO & Investment Opportunities in Australia & North America
right-arrow Created with Sketch.
NEWS The 10 hot stocks HotCopper users watchlisted in Week 30
right-arrow Created with Sketch.
NEWS Mandalay Shareholders Overwhelmingly Approve Transaction with Alkane Resources
right-arrow Created with Sketch.
NEWS Access the Latest ASX news daily on HotCopper
right-arrow Created with Sketch.
NEWS Friday's HotCopper trends: Renascor concentrate, Larvotto raise
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.